Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guangzhou Univ. of Chinese Medicine STAT3 compound c8: sourced facts only. name: "The cellular thermal shift assay (CETSA) demonstrated that c8 stabilized STAT3 protein, suggesting a potential interaction." [PMID:42759393]; target: "The cellular thermal shift assay (CETSA) demonstrated that c8 stabilized STAT3 protein, suggesting a potential interaction." [PMID:42759393]; developer: "State Key Laboratory of Traditional Chinese Medicine Syndrome/School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, People's Republic of China." [PMID:42759393]; stage: "In vivo, c8 at a dose of 25-50 mg/kg showed significant antitumor efficacy in A549 xenografts." [PMID:42759393]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guangzhou Univ. of Chinese Medicine STAT3 compound c8.